Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuiying Xu

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Scientific Reports|November 17, 2018
Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary ComplexAladdin Riad, Chenbo Zeng, Chi-Chang Weng, et al.
ACS Omega|September 18, 2018
Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in VitroChia-Ju Hsieh, Kuiying Xu, Iljung Lee, et al.
Biochemical and Biophysical Research Communications|June 22, 2019
Correlation analysis of [<sup>18</sup>F]ROStrace using ex vivo autoradiography and dihydroethidium fluorescent imaging in lipopolysaccharide-treated animalsChi-Chang Weng, Sean Carlin, Catherine Hou, et al.
Journal of Medicinal Chemistry|November 14, 2012
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosisSandrine Marchais-Oberwinkler, Kuiying Xu, Marie Wetzel, et al.
Journal of Medicinal Chemistry|November 11, 2017
Highly Selective Dopamine D<sub>3</sub> Receptor Antagonists with Arylated Diazaspiro Alkane CoresSean W Reilly, Suzy Griffin, Michelle Taylor, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
PARP-1 Expression Quantified by [<sup>18</sup>F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation TherapySamuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.
Cell Death Discovery|February 1, 2019
TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell deathChenbo Zeng, Chi-Chang Weng, Mark E Schneider, et al.
EJNMMI Research|July 27, 2022
[<sup>18</sup>F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer's disease pathology in APP/PS1 miceChia-Ju Hsieh, Catherine Hou, Yi Zhu, et al.
Biochemical and Biophysical Research Communications|October 11, 2015
The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancerMehran Makvandi, Estifanos D Tilahun, Brian P Lieberman, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 13, 2016
[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancerChristine E Edmonds, Mehran Makvandi, Brian P Lieberman, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 17, 2018
Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary ComplexAladdin Riad, Chenbo Zeng, Chi-Chang Weng, et al.
ACS Omega|September 18, 2018
Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in VitroChia-Ju Hsieh, Kuiying Xu, Iljung Lee, et al.
Biochemical and Biophysical Research Communications|June 22, 2019
Correlation analysis of [<sup>18</sup>F]ROStrace using ex vivo autoradiography and dihydroethidium fluorescent imaging in lipopolysaccharide-treated animalsChi-Chang Weng, Sean Carlin, Catherine Hou, et al.
Journal of Medicinal Chemistry|November 14, 2012
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosisSandrine Marchais-Oberwinkler, Kuiying Xu, Marie Wetzel, et al.
Journal of Medicinal Chemistry|November 11, 2017
Highly Selective Dopamine D<sub>3</sub> Receptor Antagonists with Arylated Diazaspiro Alkane CoresSean W Reilly, Suzy Griffin, Michelle Taylor, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
PARP-1 Expression Quantified by [<sup>18</sup>F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation TherapySamuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.
Cell Death Discovery|February 1, 2019
TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell deathChenbo Zeng, Chi-Chang Weng, Mark E Schneider, et al.
EJNMMI Research|July 27, 2022
[<sup>18</sup>F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer's disease pathology in APP/PS1 miceChia-Ju Hsieh, Catherine Hou, Yi Zhu, et al.
Biochemical and Biophysical Research Communications|October 11, 2015
The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancerMehran Makvandi, Estifanos D Tilahun, Brian P Lieberman, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 13, 2016
[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancerChristine E Edmonds, Mehran Makvandi, Brian P Lieberman, et al.
Pageof 5